These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11981735)

  • 1. Antifungal chemoprophylaxis after blood and marrow transplantation.
    Wingard JR
    Clin Infect Dis; 2002 May; 34(10):1386-90. PubMed ID: 11981735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.
    Hamza NS; Ghannoum MA; Lazarus HM
    Bone Marrow Transplant; 2004 Sep; 34(5):377-89. PubMed ID: 15247928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?
    Kaufman DA
    Curr Opin Pediatr; 2008 Jun; 20(3):332-40. PubMed ID: 18475105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Invasive fungal infections in patients after liver transplantation].
    Fischer L; Sterneck M
    Mycoses; 2005; 48 Suppl 1():27-35. PubMed ID: 15826284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
    Rimek D; Redetzke K; Kappe R
    Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
    Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
    Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controversy concerning optimal prophylaxis and empirical antifungal therapy in immunocompromised patients].
    Zielińska E
    Przegl Epidemiol; 2003; 57(2):299-307. PubMed ID: 12910598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R
    Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
    Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
    Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis.
    Long SS; Stevenson DK
    J Pediatr; 2005 Aug; 147(2):135-41. PubMed ID: 16126036
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.
    Oliveira JS; Kerbauy FR; Colombo AL; Bahia DM; Pinheiro GS; Silva MR; Ribeiro MS; Raineri G; Kerbauy J
    Braz J Med Biol Res; 2002 Jul; 35(7):789-98. PubMed ID: 12131918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal prophylaxis: identification of preterm neonates at highest risk for invasive fungal infection.
    Vendettuoli V; Vento G; Tirone C; Posteraro B; Romagnoli C
    Pediatrics; 2009 Feb; 123(2):e368-9. PubMed ID: 19171602
    [No Abstract]   [Full Text] [Related]  

  • 20. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.